Analysts’ Updated EPS Estimates for March 10th (ABEO, AC, ALXO, AMPX, AZO, BCIC, BDRFF, BETA, BILL, BKV)

Analysts’ updated eps estimates for Tuesday, March 10th:

Abeona Therapeutics (NASDAQ:ABEO) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.

Air Canada (TSE:AC) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. The firm currently has C$21.00 target price on the stock, down from their previous target price of C$27.00.

ALX Oncology (NASDAQ:ALXO) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $4.00 target price on the stock.

Amprius Technologies (NYSE:AMPX) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $20.00 price target on the stock.

AutoZone (NYSE:AZO) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $4,300.00 price target on the stock, up from their previous price target of $4,150.00.

Portman Ridge Finance (NASDAQ:BCIC) was downgraded by analysts at Wall Street Zen from a buy rating to a sell rating.

Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) was downgraded by analysts at Royal Bank Of Canada from a sector perform rating to an underperform rating.

BETA Technologies (NYSE:BETA) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $40.00 price target on the stock.

BILL (NYSE:BILL) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

BKV (NYSE:BKV) had its buy rating reiterated by analysts at Citigroup Inc.. Citigroup Inc. currently has a $36.00 price target on the stock.

Bunzl (LON:BNZL) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 2,200 price target on the stock.

Capricor Therapeutics (NASDAQ:CAPR) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $60.00 price target on the stock.

Casey’s General Stores (NASDAQ:CASY) had its overweight rating reissued by analysts at Stephens. They currently have a $680.00 target price on the stock.

Day One Biopharmaceuticals (NASDAQ:DAWN) had its neutral rating reaffirmed by analysts at HC Wainwright. The firm currently has a $21.50 price target on the stock, down from their previous price target of $22.00.

Dollar Tree (NASDAQ:DLTR) had its outperform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $150.00 price target on the stock.

Alpha Tau Medical (NASDAQ:DRTS) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $12.00 target price on the stock.

Foghorn Therapeutics (NASDAQ:FHTX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $13.00 price target on the stock.

Five Below (NASDAQ:FIVE) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $240.00 price target on the stock.

Guidewire Software (NYSE:GWRE) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $246.00 price target on the stock.

Intercorp Financial Services (NYSE:IFS) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Kohl’s (NYSE:KSS) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $23.00 price target on the stock.

LifeMD (NASDAQ:LFMD) had its buy rating reiterated by analysts at BTIG Research. They currently have a $10.00 price target on the stock.

lululemon athletica (NASDAQ:LULU) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $215.00 price target on the stock.

Nutanix (NASDAQ:NTNX) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at TD Cowen from a buy rating to a hold rating. The firm currently has $42.00 price target on the stock.

Ondas (NASDAQ:ONDS) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $17.00 price target on the stock.

uniQure (NASDAQ:QURE) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $70.00 price target on the stock.

RideNow Group (NASDAQ:RDNW) had its neutral rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $6.00 price target on the stock.

Cartesian Therapeutics (NASDAQ:RNAC) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $38.00 price target on the stock.

Repay (NASDAQ:RPAY) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $9.00 price target on the stock.

Signet Jewelers (NYSE:SIG) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $96.00 target price on the stock.

Semtech (NASDAQ:SMTC) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $100.00 target price on the stock, up from their previous target price of $81.00.

Spruce Biosciences (NASDAQ:SPRB) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $200.00 target price on the stock.

Talkspace (NASDAQ:TALK) had its sector weight rating reiterated by analysts at KeyCorp.

U.S. Energy (NASDAQ:USEG) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $3.50 target price on the stock.

UWM (NYSE:UWMC) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $10.00 target price on the stock.

Valt Technology Services (LON:VALT) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 6,500 price target on the stock.

Beyond Air (NASDAQ:XAIR) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 price target on the stock.

Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.